Financial BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results byTim AllenJune 17, 2024
Biologics Spine BioRestorative Therapies Announces the Appointment of Robert Paccasassi to Vice President of Quality Assurance/Regulatory Compliance byChris StewartJanuary 11, 2022
Regulatory MCRA Hires Melissa Paper, JD, MPA, CHC as Vice President of Healthcare Compliance byChris StewartOctober 21, 2021
Hospitals Regulatory Top Stories CMS proposes penalty increase for hospitals that fail to comply with price transparency rule byJosh SandbergJuly 20, 2021
Hospitals Regulatory Top Stories New Detailed Report Shows only 5.6% of Hospitals Examined are Compliant with Hospital Price Transparency Rule byChris StewartJuly 16, 2021
Financial Regulatory Xtant Medical Regains Compliance with NYSE American Continued Listing Standards byChris StewartOctober 6, 2020
Financial Hospitals Regulatory With price transparency an inevitability, hospitals need to start working toward compliance byChris StewartSeptember 15, 2020
Biologics Regulatory Bioventus Appoints Katrina Church Chief Compliance Officer byJosh SandbergAugust 24, 2020
Financial Regulatory RTI Surgical Holdings, Inc.® Receives Notification from Nasdaq Related to Delayed Annual Report on Form 10-K byChris StewartMarch 20, 2020
